Benefits of giving Pfizer jab to 5-11-year-olds ‘outweigh the risks’

Benefits of giving the Pfizer/BioNTech COVID vaccine to 5 to 11-year-olds clearly outweigh the risks, according to a US drug watchdog.

The assessment by scientists at the country’s Food and Drug Administration (FDA) comes as the makers of the vaccine said it showed 90.7% efficacy against coronavirus in a clinical trial of children in that age group.

A
Read more…

Please follow and like us: